ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04216	Ferroptosis	2/18	44/7206	0.00523965329281
ko00633	Nitrotoluene degradation	1/18	3/7206	0.00747608698407
ko00524	Neomycin, kanamycin and gentamicin biosynthesis	1/18	4/7206	0.00995636331818
ko00232	Caffeine metabolism	1/18	5/7206	0.0124307850705
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	2/18	79/7206	0.0162066433233
ko00521	Streptomycin biosynthesis	1/18	8/7206	0.0198190527855
ko00920	Sulfur metabolism	1/18	10/7206	0.0247155294517
ko05410	Hypertrophic cardiomyopathy (HCM)	2/18	100/7206	0.0252461260442
ko05414	Dilated cardiomyopathy	2/18	112/7206	0.0311493174482
ko02024	Quorum sensing	1/18	15/7206	0.0368558490676
ko04211	Longevity regulating pathway	2/18	123/7206	0.0369969456309
ko01200	Carbon metabolism	2/18	128/7206	0.0397861833941
ko04922	Glucagon signaling pathway	2/18	128/7206	0.0397861833941
ko04514	Cell adhesion molecules (CAMs)	2/18	130/7206	0.0409241015691
ko00720	Carbon fixation pathways in prokaryotes	1/18	17/7206	0.0416718967491
ko00061	Fatty acid biosynthesis	1/18	17/7206	0.0416718967491
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1/18	19/7206	0.0464651941166